Correlation Between Pfizer and Coinbase
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and Coinbase Global, you can compare the effects of market volatilities on Pfizer and Coinbase and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Coinbase. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Coinbase.
Diversification Opportunities for Pfizer and Coinbase
Poor diversification
The 3 months correlation between Pfizer and Coinbase is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Coinbase Global in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coinbase Global and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Coinbase. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coinbase Global has no effect on the direction of Pfizer i.e., Pfizer and Coinbase go up and down completely randomly.
Pair Corralation between Pfizer and Coinbase
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Coinbase. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 31.4 times less risky than Coinbase. The stock trades about -0.08 of its potential returns per unit of risk. The Coinbase Global is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 5,600 in Coinbase Global on September 3, 2024 and sell it today you would lose (325.00) from holding Coinbase Global or give up 5.8% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 97.98% |
Values | Daily Returns |
Pfizer Inc vs. Coinbase Global
Performance |
Timeline |
Pfizer Inc |
Coinbase Global |
Pfizer and Coinbase Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Coinbase
The main advantage of trading using opposite Pfizer and Coinbase positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Coinbase can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coinbase will offset losses from the drop in Coinbase's long position.Pfizer vs. Merck Company | Pfizer vs. Johnson Johnson | Pfizer vs. Highway Holdings Limited | Pfizer vs. QCR Holdings |
Coinbase vs. AEP TEX INC | Coinbase vs. US BANK NATIONAL | Coinbase vs. Jackson Financial | Coinbase vs. MetLife |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |